The rapid development of gene therapy treatments has led to a great demand for assays with quick turnaround times to
support optimization of the production of viral vectors including those based on rAAV (recombinant adeno-associated
virus) and the lentiviruses, HIV-1 (human immunodeficiency virus 1) and EIA (equine infectious anemia).
Here we report the performance of three assays run on Gyrolab® system that can be used to monitor the preparation
and purity of viral vectors:
If you have problems downloading the poster please contact email@example.com